These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17494799)

  • 21. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
    Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
    Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
    Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adherence to clinical practice guidelines for 7 chronic conditions in long-term-care patients who received pharmacist disease management services versus traditional drug regimen review.
    Horning KK; Hoehns JD; Doucette WR
    J Manag Care Pharm; 2007; 13(1):28-36. PubMed ID: 17269834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting.
    Karjalainen PP; Porela P; Ylitalo A; Vikman S; Nyman K; Vaittinen MA; Airaksinen TJ; Niemelä M; Vahlberg T; Airaksinen KE
    Eur Heart J; 2007 Mar; 28(6):726-32. PubMed ID: 17267456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.
    Fosbol EL; Wang TY; Li S; Piccini J; Lopes RD; Mills RM; Klaskala W; Thomas L; Roe MT; Peterson ED
    Am Heart J; 2013 Nov; 166(5):864-70. PubMed ID: 24176442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events.
    Zubaid M; Rashed WA; Alsheikh-Ali AA; Al-Zakwani I; AlMahmeed W; Shehab A; Sulaiman K; Qudaimi AA; Asaad N; Amin H;
    Angiology; 2015 May; 66(5):464-71. PubMed ID: 24904179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals.
    Albers GW; Yim JM; Belew KM; Bittar N; Hattemer CR; Phillips BG; Kemp S; Hall EA; Morton DJ; Vlasses PH
    Arch Intern Med; 1996 Nov; 156(20):2311-6. PubMed ID: 8911237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.
    Anavekar NS; Tleyjeh IM; Anavekar NS; Mirzoyev Z; Steckelberg JM; Haddad C; Khandaker MH; Wilson WR; Chandrasekaran K; Baddour LM
    Clin Infect Dis; 2007 May; 44(9):1180-6. PubMed ID: 17407036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early anticoagulation of bioprosthetic aortic valves in older patients: results from the Society of Thoracic Surgeons Adult Cardiac Surgery National Database.
    Brennan JM; Edwards FH; Zhao Y; O'Brien S; Booth ME; Dokholyan RS; Douglas PS; Peterson ED;
    J Am Coll Cardiol; 2012 Sep; 60(11):971-7. PubMed ID: 22921973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
    Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
    Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction.
    Mattichak SJ; Reed PS; Gallagher MJ; Boura JA; O'Neill WW; Kahn JK
    J Interv Cardiol; 2005 Jun; 18(3):163-6. PubMed ID: 15966919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
    Toepfer NJ; Baylor K; Henry Y; Simmons J; Berger PB
    Urology; 2013 Oct; 82(4):773-9. PubMed ID: 23876586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.